J&J's Bid For Crucell Hits Speed Bump With Shipment Suspension At Korean Vaccine Plant
This article was originally published in The Pink Sheet Daily
Executive Summary
The acquisition appears to be on track despite news that the Dutch biotech suspended all shipments of hepatitis B vaccine Hepavax-Gene and childhood pediatric vaccine Quinvaxem due to issues at its Korean unit.